ISSN:
eISSN:
Disciplines
(Field of Science):
- information and communication technology (Engineering and Technology)
- biomedical engineering (Engineering and Technology)
- medical biology (Medical and Health Sciences )
- pharmacology and pharmacy (Medical and Health Sciences )
- medical sciences (Medical and Health Sciences )
- health sciences (Medical and Health Sciences )
- biotechnology (Natural sciences)
- chemical sciences (Natural sciences)
(Field of Science)
Ministry points: Help
Year | Points | List |
---|---|---|
Year 2024 | 200 | Ministry scored journals list 2024 |
Year | Points | List |
---|---|---|
2024 | 200 | Ministry scored journals list 2024 |
2023 | 200 | Ministry Scored Journals List |
2022 | 200 | Ministry Scored Journals List 2019-2022 |
2021 | 200 | Ministry Scored Journals List 2019-2022 |
2020 | 200 | Ministry Scored Journals List 2019-2022 |
2019 | 200 | Ministry Scored Journals List 2019-2022 |
2018 | 45 | A |
2017 | 45 | A |
2016 | 45 | A |
2015 | 45 | A |
2014 | 45 | A |
2013 | 45 | A |
2012 | 45 | A |
2011 | 45 | A |
2010 | 32 | A |
Model:
Points CiteScore:
Year | Points |
---|---|
Year 2022 | 14.7 |
Year | Points |
---|---|
2022 | 14.7 |
2021 | 14.7 |
2020 | 14.1 |
2019 | 12.8 |
2018 | 13.6 |
2017 | 12.3 |
2016 | 11.4 |
2015 | 11 |
2014 | 9.2 |
2013 | 11.3 |
2012 | 12 |
2011 | 12.2 |
Impact Factor:
Sherpa Romeo:
Papers published in journal
Filters
total: 3
Catalog Journals
Year 2024
-
Human carnosinases: A brief history, medicinal relevance, and in silico analyses
PublicationCarnosine, an endogenous dipeptide, has been found to have a plethora of medicinal properties, such as antioxidant, antiageing, and chelating effects, but with one downside: a short half-life. Carnosinases and two hydrolytic enzymes, which remain enigmatic, are responsible for these features. Hence, here we emphasize why research is valuable for better understanding crucial concepts like ageing, neurodegradation, and cancerogenesis,...
Year 2020
-
In silico design of telomerase inhibitors.
PublicationTelomerase is a reverse transcriptase enzyme involved in DNA synthesis at the end of linear chromosomes. Unlike in most other cells, telomerase is reactivated most cancerous cells and, therefore, has become a promising new anticancer target. Despite extensive research, direct telomerase inhibitors have yet not been introduced to the clinics because of the complexity of this enzyme. Structures of this protein from simple organisms...
Year 2013
seen 487 times